Literature DB >> 3255306

Structures of duocarmycins, novel antitumor antibiotics produced by Streptomyces sp.

T Yasuzawa, T Iida, K Muroi, M Ichimura, K Takahashi, H Sano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3255306     DOI： 10.1248/cpb.36.3728

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  8 in total

1.  A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma.

Authors:  E J Small; R Figlin; D Petrylak; D J Vaughn; O Sartor; I Horak; R Pincus; A Kremer; C Bowden
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

Review 2.  Applications of Friedel-Crafts reactions in total synthesis of natural products.

Authors:  Majid M Heravi; Vahideh Zadsirjan; Pegah Saedi; Tayebeh Momeni
Journal:  RSC Adv       Date:  2018-12-03       Impact factor: 4.036

3.  The reversible DNA-alkylating activity of duocarmycin and its analogues.

Authors:  A Asai; S Nagamura; H Saito; I Takahashi; H Nakano
Journal:  Nucleic Acids Res       Date:  1994-01-11       Impact factor: 16.971

Review 4.  CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.

Authors:  D L Boger; D S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

5.  Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody-Drug Conjugate Payload.

Authors:  Sean W Smith; Vasu Jammalamadaka; Dmitry Borkin; Jianyu Zhu; Sylvia J Degrado; Jennifer Lu; Jianqing Huang; Ying-Ping Jiang; Nareshkumar Jain; Jagath R Junutula
Journal:  ACS Med Chem Lett       Date:  2017-12-06       Impact factor: 4.345

Review 6.  Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs.

Authors:  Elena Díaz-Rodríguez; Lucía Gandullo-Sánchez; Alberto Ocaña; Atanasio Pandiella
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

7.  Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.

Authors:  K Gomi; E Kobayashi; K Miyoshi; T Ashizawa; A Okamoto; T Ogawa; S Katsumata; A Mihara; M Okabe; T Hirata
Journal:  Jpn J Cancer Res       Date:  1992-01

8.  Cyclization of free radicals at the C-7 position of ethyl indole-2-carboxylate derivatives: an entry to a new class of Duocarmycin Analogues.

Authors:  Naim H Al-Said; Khaled Q Shawakfeh; Wasim N Abdullah
Journal:  Molecules       Date:  2005-12-31       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.